voxelotor
Global Blood Therapeutics
[]
$gbt gbt presents positive new real-world evidence data at eha2022 congress further supporting clinical use of oxbryta (voxelotor) in sickle cell disease stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.